Table 2.
Intake | Groups | Baseline | Week 12 |
---|---|---|---|
Energy (kcal/d) | Pomegranate | 1,784±238b | 1,787±233b |
Placebo | 2,028±241 | 2,011±221 | |
Protein (g/d) | Pomegranate | 54±12 | 58±12 |
Placebo | 59±10 | 65±9 | |
Carbohydrate (g/d) | Pomegranate | 234±35 | 266±41b |
Placebo | 232±27 | 257±37 | |
Fiber (g/d) | Pomegranate | 15±4 | 15±3 |
Placebo | 16±3 | 15±4 | |
Fat (g/d) | Pomegranate | 73±20 | 72±19 |
Placebo | 84±15 | 83±19 | |
SAFA (g/d) | Pomegranate | 16.2±5.5 | 17.2±6.4 |
Placebo | 23.7±8.8 | 21.3±8.2 | |
MUFA (g/d) | Pomegranate | 30.7±11 | 29.8±8.8 |
Placebo | 32.5±6.1 | 33.6±8.7 | |
PUFA (g/d) | Pomegranate | 21.4±6.7 | 19.4±4.4 |
Placebo | 20.5±6.1 | 21.7±5.9 | |
Cholesterol (mg/d) | Pomegranate | 134.3±60.7 | 136.1±48.6 |
Placebo | 169.6±78 | 189.9±58.2 | |
Vitamin E (mg/d) | Pomegranate | 22.7±5.9 | 20.7±4.7 |
Placebo | 20.5±6.6 | 22.1±6.6 | |
Vitamin C (mg/d) | Pomegranate | 78.7±54.3 | 77.3±32.9 |
Placebo | 60.1±32.8 | 66.6±32.1 | |
Vitamin A (μg/d) | Pomegranate | 559.7±478.3 | 719.9±609 |
Placebo | 440.8±349.4 | 359.7±170.2 |
BMI: body mass index; MUFA: monounsaturated fatty acids; SAFA: saturated fatty acids; PUFA: polyunsaturated fatty acids.
All values are presented as mean±SD.
n=22 for all values.
P<0.05 versus the placebo group.